Kanabo Group plc announced the expansion of its online clinic, Treat It, to include specialised mental health treatments. This expansion comes at a time when national mental health infrastructure is under extreme pressure, and this service will allow individuals who are suffering from conditions such as anxiety, PTSD or ADHD to securely access to treatments through the Group's digital health platform. As with Treat It's existing pain management offering, the mental health service will focus on secondary care, including prescriptions for alternative medications such as medical cannabis.

While studies on the efficacy of medical cannabis in this area remain nascent, some evidence indicates that medicinal cannabis may help alleviate symptoms of conditions such as PTSD. Mental Health in the UK: In 2022, around one in six adults experienced moderate to severe depressive symptoms, an increase from pre-pandemic levels. In the fourth quarter of 2023, around 22% of the adult population experienced a high level of anxiety.

The non-profit organisation PTSD estimates that around 1 in 10 people in the UK, or around 6.6 million people, might experience PTSD during their lifetime. Meanwhile, mental health services are underserved, with the national situation being described as a crisis or an emergency. This new Clinic offering will provide patients for whom other therapies and medications may not have worked with new opportunities to treat their ailments.